Gold Nanoparticles Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 10.00 % |
| Fastest Growing Market | Europe |
| Largest Market | North America |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gold Nanoparticles Market Analysis
The gold nanoparticles market is expected to register a CAGR of over 10% during the forecast period.
COVID-19 negatively affected the market studied in recent times. The electronics industry which is a major consumer of gold nanoparticles was severely impacted by the pandemic. However, the increasing demand for electronic products in 2021, is likely to encourage the gold nanoparticles market in the coming years.
- Over the mid-term, the major factors driving the market studied are rising nanotechnology applications in the medical industry and rising demand from the high-end electronics sector.
- On the flip side, volatility in the price of gold is expected to hinder the growth of the market studied.
- Innovation in the field of electronics is likely to act as an opportunity for the market studied during the forecast period.
- North America region is expected to dominate the global nanoparticles market; while North America is expected to register the fastest growth through the forecast period.
Gold Nanoparticles Market Trends
Targeted Drug Delivery to Dominate the Market
- The targeted delivery of drugs is one of the most important uses for gold nanoparticles on the market.
- A target drug delivery system is an advanced form of drug delivery where the medication drug or a pharmacologically active agent is selectively delivered by the nanoparticles at an exact corresponding site of action or absorption and not to the non-target organs, tissues, or cells.
- The addition of nanoparticles to the targeted drug delivery system has led to many benefits, such as high therapeutic efficacy, high targeting efficiency, and repeatability.
- Gold nanoparticles are used to deliver multiple drug molecules, vaccines, recombinant proteins, or nucleotides into their targets and can also control the volume of drug released via biological stimuli (internal) or light activation (external).
- In the United States in 2021, overall pharmaceutical expenditures grew by 7.7% compared to 2020, for a total of USD 576.9 billion. Additionally, the Centers for Medicare and Medicaid Services reported prescription drug expenditure in the United States came to some USD 378 billion in 2021. The rising elderly population and increasing health risks among individuals are only expected to drive the market for targeted drug deliveries and hence gold nanoparticles in this sector.
- In China, the pharmaceutical industry generated revenue of over CNY 3.3 trillion (USD 511 billion) in 2021, representing year-on-year growth of almost 20 percent. Pharmaceutical preparations manufacturing and Chinese patent drug manufacturing are the two biggest pharmaceutical segments in the country.
- One of the other uses of gold nanoparticles is that their surface can be modified using some specialty polymers, like polyethylene glycol (PEG). This is expected to result in increased stability of gold nanoparticles in different physiological conditions and also provide a variety of combinations of gold nanoparticles. This is further expected to boost the usage of gold nanoparticles in treated drug delivery applications.
- Therefore, all the above-mentioned factors are expected to drive demand for the market studied in the coming years.
North America to Dominate the Market
- During the forecast period, the gold nanoparticles market is expected to be led by North America.
- The United States' medical technology industry is still one of the most important and fastest-growing industries in the area. It is also a leading force in the revolution that is changing the healthcare system.
- The United States' healthcare spending grew 2.7 percent in 2021, reaching USD 4.3 trillion, or USD 12,914 per person. 18.3 percent of the country's gross domestic product went toward health care costs.The growth is expected to continue through the upcoming years, too.
- The country's medical technology is one of the best in the world, with cutting-edge products that save and improve lives. Because the country put a lot of money into research and development, its medical technology set the standard for growth, employment trends, production values, exports, global market share, and venture capital financing.
- Also, about 35% to 40% of all medical devices made in the United States are exported, and the same amount of medical devices used in the United States are brought in from other countries. About 40% to 50% of the total revenue of U.S. medical device companies, which includes the revenue of their foreign subsidiaries, comes from sales in other countries.
- American hospitals spend around USD 93 billion per year on service to cover the medical device's lifecycle cost.
- The breakthroughs in areas such as device miniaturization and nanotechnology have created vast opportunities for the growth of the gold nanoparticle market in the United States.
- Also, by 2021, Canada's total health care costs were expected to have risen to more than USD 308 billion, or USD 8,019 per Canadian.In 2021, hospitals (25% of total health spending), drugs (14%), and physicians (13% of total health spending) accounted for the largest shares of health spending (over 50% of total health spending). Spending on drugs also went up because claims for specialty drugs kept growing and because chronic maintenance drug users had higher costs per claimant.
- Also, because technology and research and development (R&D) in the electronics industry are changing quickly, there is a lot of demand for newer and faster electronics. There is a spurt in the number of manufacturing plants and development centers in the United States that are focusing on high-end products, which is expected to boost the demand for gold nanoparticles over the forecast period.
- The Canadian consumer electronics industry experienced growth and grabbed new opportunities in the key product category, as Canadians valued new product innovations. The factor driving the growth of this industry is the improved network connectivity in the country. The Canadian consumer electronics market reached USD 19.7 billion in revenue by August 2022. Samsung is the second-most popular smartphone brand in Canada after Apple.
- Because of all of these things, the market for gold nanoparticles in the region is expected to grow quickly over the next few years.
Gold Nanoparticles Industry Overview
The gold nanoparticles market is partially consolidated in nature. The major companies in the market studied include Merck KGaA, BBI Solutions, Tanaka Holdings Co. Ltd., Nanocomposix, and Cytodiagnostics Inc., among others (not in any particular order).
Gold Nanoparticles Market Leaders
-
Merck KGaA
-
TANAKA HOLDINGS Co., Ltd.
-
Cytodiagnostics Inc.
-
BBI Solutions
-
nanoComposix
*Disclaimer: Major Players sorted in no particular order
Gold Nanoparticles Market News
Recent developments pertaining to the market studied will be covered in the final report.
Gold Nanoparticles Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
-
4.1 Drivers
- 4.1.1 Rising Nanotechnology Applications in the Medical Industry
- 4.1.2 Rising Demand from the High-end Electronics Sector
-
4.2 Restraints
- 4.2.1 Volatility in Price of Gold
- 4.3 Industry Value-Chain Analysis
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products and Services
- 4.4.5 Degree of Competition
5. MARKET SEGMENTATION (Market Size in Value)
-
5.1 Application
- 5.1.1 Imaging
- 5.1.2 Targeted Drug Delivery
- 5.1.3 Sensors
- 5.1.4 In Vitro Diagnostics
- 5.1.5 Probes
- 5.1.6 Catalysis
- 5.1.7 Other Applications
-
5.2 End-user Industry
- 5.2.1 Electronics
- 5.2.2 Healthcare
- 5.2.3 Chemicals
- 5.2.4 Other End-user Industries
-
5.3 Geography
- 5.3.1 Asia-Pacific
- 5.3.1.1 China
- 5.3.1.2 India
- 5.3.1.3 Japan
- 5.3.1.4 South Korea
- 5.3.1.5 Rest of Asia-Pacific
- 5.3.2 North America
- 5.3.2.1 United States
- 5.3.2.2 Canada
- 5.3.2.3 Mexico
- 5.3.3 Europe
- 5.3.3.1 Germany
- 5.3.3.2 United Kingdom
- 5.3.3.3 Italy
- 5.3.3.4 France
- 5.3.3.5 Rest of Europe
- 5.3.4 Rest of the World
- 5.3.4.1 South America
- 5.3.4.2 Middle-East and Africa
6. COMPETITIVE LANDSCAPE
- 6.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
- 6.2 Market Share (%) Analysis **/ Market Ranking Analysis
- 6.3 Strategies Adopted by Leading Players
-
6.4 Company Profiles
- 6.4.1 Aurion
- 6.4.2 BBI Solutions
- 6.4.3 Cline Scientific AB
- 6.4.4 Cytodiagnostics Inc.
- 6.4.5 Sona Nanotech.
- 6.4.6 Meliorum Technologies Inc.
- 6.4.7 Merck KGaA
- 6.4.8 nanoComposix
- 6.4.9 NanoHybrids
- 6.4.10 NANOPARTZ INC.
- 6.4.11 TANAKA HOLDINGS Co., Ltd.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
- 7.1 Innovation in the Field of Electronics
- 7.2 Other Opportunities
Gold Nanoparticles Industry Segmentation
Gold nanoparticles are small gold particles with a diameter of 1-100 nanometers that, once dispersed in water, are known as colloidal gold. Gold nanoparticles are widely used in electronics, photodynamic therapy, therapeutic agent delivery, sensors, probes, diagnostics, and as catalysts in a number of chemical reactions. The market is segmented by application, end-user industry, and geography. By application, the market is segmented into imaging, targeted drug delivery, sensors, in vitro diagnostics, probes, catalysis, and other applications. By end-user industry, the market is segmented into electronics, healthcare, chemicals, and other end-user industries. The report also covers the market size and forecasts for the gold nanoparticles market in 11 countries across major regions. For each segment, the market sizing and forecasts have been done on the basis of revenue (USD million).
| Application | Imaging | |
| Targeted Drug Delivery | ||
| Sensors | ||
| In Vitro Diagnostics | ||
| Probes | ||
| Catalysis | ||
| Other Applications | ||
| End-user Industry | Electronics | |
| Healthcare | ||
| Chemicals | ||
| Other End-user Industries | ||
| Geography | Asia-Pacific | China |
| India | ||
| Japan | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| Italy | ||
| France | ||
| Rest of Europe | ||
| Geography | Rest of the World | South America |
| Middle-East and Africa |
Gold Nanoparticles Market Research FAQs
What is the current Gold Nanoparticles Market size?
The Gold Nanoparticles Market is projected to register a CAGR of greater than 10% during the forecast period (2024-2029)
Who are the key players in Gold Nanoparticles Market?
Merck KGaA, TANAKA HOLDINGS Co., Ltd., Cytodiagnostics Inc., BBI Solutions and nanoComposix are the major companies operating in the Gold Nanoparticles Market.
Which is the fastest growing region in Gold Nanoparticles Market?
Europe is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Gold Nanoparticles Market?
In 2024, the North America accounts for the largest market share in Gold Nanoparticles Market.
What years does this Gold Nanoparticles Market cover?
The report covers the Gold Nanoparticles Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gold Nanoparticles Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Gold Nanoparticles Industry Report
Statistics for the 2024 Gold Nanoparticles market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Gold Nanoparticles analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
